Anthropic is considering an earlier release of its next AI model as competition intensifies ahead of a possible initial public offering, according to Reuters. No launch has been announced, and the timing remains under review while the company evaluates safety and profitability trade-offs.
The investor takeaway is not a simple product-catalyst story. Anthropic's reported growth is exceptional, but the durability of that growth will depend on enterprise retention, pricing power, compute economics and the pace at which open-weight models narrow the capability gap.
What is confirmed—and what remains reported
Reuters reported that Anthropic's annualized revenue run rate exceeded $65 billion by the end of July, up from about $9 billion at the end of 2025. It also reported company projections of roughly $190 billion to $200 billion of revenue in 2028. These are private-company figures reported by news organizations, not audited public-company disclosures.
The same report said Anthropic could delay its IPO until after the November U.S. midterm elections. Investors should treat that as a possible timetable, not a fixed listing date. The company has not published a final prospectus in the sources reviewed for this article.
Separately, Anthropic said Claude now leads 26% of its model research and development tasks end-to-end under human supervision, while roughly 90% of R&D involves some collaboration with Claude. That is evidence of internal productivity gains, but it is not equivalent to autonomous model development.
The competitive question behind the model release
Reuters reported that OpenAI's GPT-6 Astra has gained enterprise traction since its September release. Third-party data cited in that report showed Astra at about 13% of enterprise AI spending tracked by Ramp, versus roughly 8% for Anthropic's Claude Fable, while OpenRouter spending shifted toward OpenAI models for the first time in more than two years.
Those indicators are useful but incomplete. Expense-platform and routing data do not capture every direct enterprise contract, negotiated price or cloud-partner resale. Leadership can also change quickly as vendors release new models. Investors should therefore focus on retention, net revenue expansion and unit economics rather than a single benchmark or traffic snapshot.
Implications for public-market investors
| Exposure | Potential upside | Key risk |
|---|---|---|
| Cloud and distribution partners | Higher model usage can lift infrastructure demand. | Revenue sharing and customer bargaining power may compress margins. |
| AI accelerators and data-centre suppliers | Faster model cycles support compute demand. | Efficiency gains or weaker funding conditions could slow capital expenditure. |
| Application software | More capable models enable new products and automation. | Model vendors may move up the stack and pressure software pricing. |
A bullish reading is that Anthropic is converting research capability into rapid enterprise revenue while using Claude to accelerate its own development process. A bearish reading is that model advantages are short-lived, competition is reducing switching costs, and headline revenue may overstate economic value if compute, training and partner payments remain high.
The higher-rate environment matters as well. When discount rates rise, public investors generally demand clearer evidence of durable free cash flow. For Anthropic, a new model could defend market share, but it could also require more inference subsidies, training expense and safety investment.
What to monitor before an IPO
- Prospectus quality: audited revenue, gross margin after compute and distribution payments, cash flow and contractual obligations.
- Customer concentration: dependence on a small number of cloud partners or large enterprise accounts.
- Revenue durability: retention, usage growth and price per unit of useful work.
- Capital intensity: training and inference commitments relative to operating cash generation.
- Governance and safety: how release controls interact with commercial targets and regulatory scrutiny.
Until those disclosures arrive, a reported revenue run rate is best treated as a growth signal rather than a complete valuation framework.